Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
WuXi Shares Lose $17 Billion on Fear US to Target China Biotech.
In: Bloomberg.com, 2024-02-02, S. N.PAG
Online
serialPeriodical
Zugriff:
WuXi AppTec Co., a Chinese medical technology company, has experienced significant losses in Hong Kong due to concerns over proposed US legislation that would ban the company and its units from government contracts. The stock prices of WuXi AppTec and its subsidiary, WuXi Biologics Cayman Inc., have reached their lowest levels since 2019. The legislation aims to block Chinese biotech companies, which are believed to be controlled by the Communist Party and pose a national security risk, from accessing federal contracts. The proposal has resulted in a combined $17 billion loss in market capitalization for WuXi AppTec and WuXi Biologics. [Extracted from the article]
Titel: |
WuXi Shares Lose $17 Billion on Fear US to Target China Biotech.
|
---|---|
Autor/in / Beteiligte Person: | Yang, Charlotte |
Zeitschrift: | Bloomberg.com, 2024-02-02, S. N.PAG |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|